SHOFU (7979) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The cumulative results for Q3 reflected higher revenue but lower earnings, with the key factor being that the increase in SG&A expenses more than offset the benefit from higher revenue. Revenue was ¥291.1B (+0.9% YoY), Operating Income was ¥38.1B (△11.4%), Ordinary Income was ¥41.8B (△6.9%), and net income attributable to owners of the parent was ¥34.2B (△2.1%). Although the gross profit margin remained high at 59.6%, the SG&A ratio rose to 46.5%, causing the Operating Income margin to decline from 14.9% in the previous year to 13.1%. Net Income includes a gain on the sale of investment securities of ¥7.6B; therefore, it is appropriate to assess underlying earnings power based on the Ordinary Income level after excluding this extraordinary gain.

Factors Affecting Earnings

【Revenue】Revenue was ¥291.1B, representing a modest 0.9% increase YoY. By segment, DentalRelated was ¥274.1B (94.4% of total), accounting for the majority of revenue and serving as the core earnings pillar with Operating Income of ¥39.0B and a margin of 14.2%. Meanwhile, NailRelated generated only ¥16.2B in revenue, with an Operating Income loss of △¥1.0B and a margin of △6.0%, weighing down the company-wide profit margin.

【Profit and Loss】The cost-of-sales ratio was nearly unchanged from the previous year, allowing the company to maintain a gross profit margin of 59.6%. However, SG&A expenses increased from ¥12.9B in the previous year to ¥13.5B, causing the SG&A ratio to rise from 44.7% to 46.5%. This increase in SG&A expenses absorbed the benefit of higher revenue, and Operating Income declined 11.4% to ¥38.1B (¥43.0B in the previous year). Non-operating income of ¥6.6B, including dividend income of ¥1.5B and foreign exchange gains of ¥1.1B, partially offset the decline, limiting the decrease in Ordinary Income to ¥41.8B (△6.9%). However, following the recognition of a ¥7.6B gain on the sale of investment securities as extraordinary income, the decline in Net Income narrowed to ¥34.2B (△2.1%). In conclusion, the current period saw higher revenue but lower earnings, primarily due to the increased burden of SG&A expenses.

Segment Analysis

DentalRelated generated revenue of ¥274.1B (94.4% of the company total), Operating Income of ¥39.0B, and a margin of 14.2%, making it the effective source of the company’s overall earnings. NailRelated generated only ¥16.2B in revenue and recorded an Operating Income loss of △¥1.0B (margin of △6.0%), with the low profitability of this segment weighing down the company-wide Operating Income margin. The gap between the profit margins of the two segments exceeded 20 points, indicating that the earnings structure is highly dependent on DentalRelated.

Key Financial Indicators

【Profitability】The gross profit margin was 59.6%, the Operating Income margin was 13.1%, the Ordinary Income margin was 14.4%, and the Net Income margin was 11.7%, all of which remained at high levels. However, the Operating Income margin declined by approximately 1.8pt from 14.9% in the same period of the previous year, indicating that the increase in SG&A expenses exceeded the benefit from higher revenue.【Cash Flow Quality】Net Income includes a ¥7.6B gain on the sale of investment securities, equivalent to 22.2% of Net Income. Ordinary Income of ¥41.8B more closely reflects recurring earnings power.【Investment Efficiency】ROE was 7.5%. Despite the high Net Income margin, the total asset turnover ratio was low, while asset concentration in inventories of ¥102.4B (19.2% of total assets) and investment securities of ¥89.1B (16.7% of total assets) constrained capital efficiency.【Financial Soundness】The Equity Ratio was 85.6%, and the current ratio was approximately 526% (current assets of ¥289.8B / current liabilities of ¥55.0B). With virtually no interest-bearing debt, the financial foundation is extremely conservative.

Cash Flow Analysis

Although the cash flow statement was not disclosed, an examination of funding trends based on changes in the balance sheet shows that cash and deposits declined from ¥106.5B in the previous year to ¥97.7B, while inventories increased from ¥82.0B to ¥102.4B and property, plant and equipment increased from ¥106.0B to ¥121.8B. This suggests that funds may have been allocated to inventory accumulation and capital investment. Accounts receivable declined to ¥38.7B from ¥41.6B in the previous year, while accounts payable also declined to ¥10.6B from ¥12.3B, indicating that the impact of working capital compression was limited. Retained earnings increased from ¥239.0B to ¥254.6B, suggesting that asset formation funded by retained earnings is progressing. Net assets increased from ¥427.4B to ¥456.4B, indicating that funds were primarily allocated to expanding equity and reinvesting in assets.

Earnings Quality

Of the current period’s pretax income of ¥49.4B, a ¥7.6B gain on the sale of investment securities was recognized as extraordinary income. Excluding this non-recurring item, pretax income would have been equivalent to ¥41.8B, nearly matching Ordinary Income of ¥41.8B. Non-operating income of ¥6.6B consisted of dividend income of ¥1.5B, foreign exchange gains of ¥1.1B, and other income of ¥2.3B, with non-core income contributing to the increase in Ordinary Income. The extraordinary gain of ¥7.6B accounted for 22.2% of net income attributable to owners of the parent of ¥34.1B, indicating that a certain portion of Net Income was generated by non-recurring factors. Accordingly, when assessing earnings quality, Operating Income and Ordinary Income should be emphasized over Net Income as indicators of sustainable earnings power. Comprehensive income was ¥46.9B, exceeding Net Income of ¥34.2B, with positive contributions from foreign currency translation adjustments of ¥7.6B and valuation differences on securities of ¥5.8B. These items, however, are also non-recurring factors subject to market fluctuations.

Earnings Forecast and Guidance

Progress against the company’s Full-Year forecast was 71.2% for Revenue (forecast: ¥408.8B), 72.7% for Operating Income (forecast: ¥52.4B), 78.0% for Ordinary Income (forecast: ¥53.6B), and 72.6% for Net Income (based on assumed Net Income). The Full-Year forecast anticipates a 5.6% increase in Revenue but a △2.9% decline in both Operating Income and Ordinary Income, indicating that the company has incorporated lower profit margins into its plan. The Revenue required in Q4 is ¥117.6B, while the required Operating Income is ¥14.3B. The required Operating Income margin is 12.2%, below the 13.1% achieved in the cumulative Q3 period, meaning the hurdle for achieving the plan is not relatively high.

Shareholder Returns

The Q2 dividend was ¥21.0 per share, while the Full-Year dividend forecast is ¥53.0. Based on forecast Full-Year Net Income of ¥47.0B and an average number of shares outstanding during the period of 3,557万 shares, the forecast Payout Ratio is approximately 40.1%, representing a stable level of profit distribution. The financial foundation, comprising net assets of ¥456.4B and an Equity Ratio of 85.6%, supports dividend sustainability. However, there was no disclosure regarding share buybacks, and this report evaluates only the Payout Ratio.

Risk Factors

1. Profitability deterioration risk: While Revenue increased only 0.9% YoY, the SG&A ratio rose from 44.7% to 46.5%, and the Operating Income margin declined by approximately 1.8pt. If expense growth exceeding the benefit from higher revenue continues, further deterioration in profit margins is a concern.

2. Segment profitability disparity risk: NailRelated recorded a ¥16.2B Revenue and an Operating Income loss of △¥1.0B, with the gap versus DentalRelated’s 14.2% margin weighing down the company-wide profit margin.

3. Dependence on extraordinary income risk: Of net income attributable to owners of the parent of ¥34.2B, the ¥7.6B gain on the sale of investment securities accounted for 22.2%. This gain is non-recurring, and there is no guarantee that Net Income will be generated at the same level in the following periods.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Return

Both the Operating Income margin and Net Income margin were substantially above the industry median, placing the company’s profitability among the higher-ranking companies in the industry.

Growth and Capital Efficiency

The Revenue growth rate was below the industry median, indicating that growth was somewhat less impressive relative to the company’s high profitability.

※Source: Compiled by the Company

Key Points in the Financial Results

1. The Operating Income margin declined from 14.9% in the same period of the previous year to 13.1%, as the increase in the SG&A ratio exceeded the benefit from higher revenue. Attention should be paid to whether SG&A trends from Q4 onward will become a turning point in the profit margin trend.

2. Net Income of ¥34.2B includes a ¥7.6B gain on the sale of investment securities, equivalent to 22.2%. When assessing recurring earnings power, it is useful to verify results based on Operating Income and Ordinary Income.

3. The Full-Year plan incorporates a 5.6% increase in Revenue but a △2.9% decline in Operating Income. Since the Operating Income margin required in Q4 is 12.2%, below the 13.1% achieved in the cumulative Q3 period, the hurdle for achieving the plan is relatively low.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,292–¥1,367 at Cost of Equity ±1%, and ¥1,328–¥1,331 at ω±0.1.

Notes:

• Net assets as of the quarter-end are used (there is a timing gap relative to the Full-Year forecast).

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / These are mechanically calculated values based solely on publicly disclosed data and do not constitute forecasts of the market share price or recommendations for specific investment actions, nor do they predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings release data. It does not constitute a recommendation to invest in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Shofu delivered modest top-line growth through FY2026 Q3, but operating performance weakened as SG&A growth materially outpaced revenue growth. Revenue increased 0.9% YoY to ¥29.114bn. Gross profit rose 1.0% to ¥17.351bn, preserving a gross margin of 59.6%. However, SG&A expenses increased 5.2% YoY to ¥13.545bn, compared with only 0.9% revenue growth. Consequently, operating income declined 11.4% YoY to ¥3.806bn. The operating margin compressed by 182bp YoY to 13.1% from 14.9%. Ordinary income declined 6.9% to ¥4.182bn, with the reduction partly cushioned by higher non-operating income. Net income attributable to owners fell only 2.1% to ¥3.412bn, equating to a still-strong 11.7% net margin. The smaller decline in net income than in operating income reflects a ¥0.758bn gain on sales of investment securities, versus ¥0.378bn in the prior-year period. This non-recurring gain represented 22.2% of reported net income and materially supported bottom-line resilience. Excluding the pre-tax securities-sale gain, profit before tax would have been ¥4.183bn, broadly equal to reported ordinary income. The balance sheet remains highly conservative, with equity accounting for 85.6% of total assets and a current ratio of 526.6%. Cash and deposits of ¥9.772bn and investment securities of ¥8.911bn provide substantial liquidity and financial flexibility. The principal operating concern is working-capital intensity, particularly the 24.9% YoY rise in inventories to ¥10.237bn. Quality alerts indicate inventory days of 327 days and 238 days, as well as a 338-day cash conversion cycle, all substantially above manufacturing benchmarks. These metrics raise the risk that capital is tied up in finished goods and that inventory normalization could pressure future production, margins, or cash generation. Against full-year guidance, Q3 cumulative revenue progress is 71.2%, operating-income progress is 72.7%, and net-income progress is 72.6%, all moderately below the standard 75% seasonal run-rate. Full-year targets remain within reach, but achieving them requires a stronger Q4 than implied by the year-to-date revenue and operating-profit trajectory. The earnings profile therefore combines solid underlying profitability and exceptional balance-sheet strength with declining operating leverage, non-recurring support to net income, and elevated inventory-related execution risk.

Profitability Analysis

Annualized DuPont ROE is 10.0%, comprising a 11.7% net profit margin, 0.728x asset turnover, and 1.17x financial leverage. The company generates its return primarily through a high margin and conservative capital structure rather than balance-sheet leverage. Financial leverage is low, consistent with equity of ¥45.637bn against total liabilities of ¥7.698bn, and therefore does not introduce material financing-driven volatility into ROE. Asset turnover of 0.728x is modest, reflecting a balance sheet with meaningful inventory, cash, PPE, and investment-security holdings relative to revenue. The largest adverse operating change was margin compression rather than sales contraction: revenue grew 0.9%, while operating income declined 11.4%. Gross margin was essentially stable at 59.6%, improving by approximately 5bp from 59.5% in the prior period. This indicates that the principal pressure arose below gross profit. SG&A represented 46.5% of revenue, up from 44.7% a year earlier, an approximately 187bp increase. The resulting operating-margin decline to 13.1% from 14.9% demonstrates negative operating leverage during the period. Despite this compression, a 13.1% operating margin remains within the "good" range under the provided profitability benchmarks. Ordinary margin declined by approximately 121bp to 14.4%, as the growth in non-operating income did not fully offset weaker operating earnings. Net margin declined by only around 36bp to 11.7%, but this apparent resilience was materially assisted by the gain on sales of investment securities. The ¥0.758bn securities gain was equivalent to 19.9% of operating income and 22.2% of net income, making reported net profitability less representative of recurring earning power. The tax burden was 0.691, slightly below the 0.70 normal benchmark, corresponding to an effective tax rate of 30.8%. Interest expense was only ¥0.006bn and interest coverage was 634.33x, confirming that financing costs are immaterial to profitability. FX gains of ¥0.113bn were equal to only 3.0% of operating income, indicating a limited reported currency contribution to the period's earnings.

Growth Assessment

Revenue growth of 0.9% YoY was subdued relative to the full-year forecast of 5.6% growth. The company recorded ¥29.114bn of revenue through Q3, equal to 71.2% of the ¥40.876bn full-year forecast. This is 3.8 percentage points below the standard 75% Q3 progress rate, implying that Q4 revenue needs to reach ¥11.762bn to achieve guidance. Operating income of ¥3.806bn represents 72.7% of the ¥5.236bn full-year target, 2.3 percentage points below the standard Q3 progress rate. Q4 operating income of ¥1.430bn is required to meet the full-year forecast. Ordinary income progress is 78.0% of the ¥5.363bn forecast, supported by non-operating income and already above the standard 75% pace. Net income attributable to owners stands at 72.6% of the ¥4.701bn forecast, requiring ¥1.289bn in Q4. The operating-income forecast implies a full-year operating margin of 12.8%, slightly below the 13.1% achieved through Q3, so the full-year operating target is arithmetically achievable despite below-standard cumulative progress. However, the revenue target requires a material sequential acceleration in Q4, while year-to-date operating leverage has been unfavorable. Gross-profit stability supports the view that core pricing and product mix have remained relatively resilient. Conversely, the 5.2% increase in SG&A against 0.9% revenue growth needs to moderate or be absorbed by higher sales in Q4 for margin recovery. Finished-goods inventory was ¥10.237bn, up 24.9% YoY, which may reflect preparation for demand, product availability requirements, or slower sell-through. Given the exceptionally long reported inventory and cash-conversion periods, the inventory build should be assessed primarily through subsequent sales growth and inventory normalization. The ¥0.758bn gain on sales of investment securities improved reported profit growth but does not strengthen recurring operating growth. Comprehensive income more than doubled to ¥4.692bn, mainly supported by positive valuation and foreign-currency translation movements, rather than by a comparable acceleration in operating earnings.

Financial Health

Financial health is exceptionally strong. Total equity was ¥45.637bn, equivalent to 85.6% of total assets of ¥53.336bn. Total liabilities were only ¥7.698bn, or 14.4% of total assets. The debt-to-equity ratio was 0.17x, well below the 1.0x conservative-capital-structure benchmark and far from the 2.0x warning threshold. The current ratio was 526.6% and the quick ratio was 340.6%, indicating substantial coverage of current obligations. Working capital was ¥23.476bn. Current assets of ¥28.979bn exceeded current liabilities of ¥5.503bn by a wide margin. Cash and deposits totaled ¥9.772bn, while investment securities totaled ¥8.911bn, together representing 35.0% of total assets. This liquidity buffer materially reduces refinancing and near-term maturity-mismatch risk. Accounts payable were only ¥1.057bn, compared with inventories of ¥10.237bn, which contributes to the working-capital funding burden but is readily manageable given the cash-rich balance sheet. Current liabilities include ¥2.600bn of contract liabilities, which provides some operating funding and reflects obligations to deliver goods or services. Net defined-benefit liabilities were ¥0.221bn, modest relative to equity. Intangible assets were ¥0.635bn, or 1.2% of total assets, indicating that the asset base is not materially dependent on capitalized intangibles. Investment securities represented 16.7% of total assets, and their size makes market valuation movements and future portfolio monetization relevant to equity and non-operating earnings. No balance-sheet leverage warning is triggered; the key balance-sheet issue is capital efficiency rather than solvency.

Notable B/S Changes

Inventories: +¥2.042bn (+24.9%) to ¥10.237bn - growth far exceeded revenue growth; elevated DIO and cash-conversion-cycle alerts make sell-through and obsolescence risk key monitoring items. Property, plant and equipment: +¥1.576bn (+14.9%) to ¥12.179bn - indicates a larger operating asset base and raises the importance of adequate utilization and return generation. Total assets: +¥3.342bn (+6.7%) to ¥53.336bn - asset growth was led by inventories and PPE, increasing capital employed faster than revenue. Cash and deposits: -¥0.881bn (-8.3%) to ¥9.772bn - liquidity remains ample, but the decline alongside higher inventories is consistent with greater working-capital absorption. Accumulated other comprehensive income: +¥1.267bn (+18.6%) to ¥8.085bn - primarily reflects favorable securities valuation and foreign-currency translation movements, increasing equity sensitivity to market and FX changes. Total equity: +¥2.901bn (+6.8%) to ¥45.637bn - continued capital accumulation preserved an exceptionally high 85.6% equity ratio. Investment securities: +¥0.202bn (+2.3%) to ¥8.911bn - portfolio remains material at 16.7% of total assets; valuation changes and potential disposals can affect comprehensive and reported income.

Cash Flow Quality

Working-capital conditions are the principal cash-flow-quality issue. Inventories increased by ¥2.042bn YoY to ¥10.237bn, a 24.9% increase that substantially exceeded the 0.9% increase in revenue. The inventory balance represented 19.2% of total assets and 35.2% of cumulative Q3 revenue. The first HIGH_INVENTORY_DAYS alert, reporting DIO of 327 days, is concerning because it indicates a very long period of capital being held in stock relative to annualized cost of sales. For a manufacturer, such a level can signal slow-moving stock, demand timing risk, elevated safety stock, or product-mix complexity. The 327-day measure is far above the 90-day warning level and therefore has a high potential impact on future inventory write-down risk and working-capital release potential. The second HIGH_INVENTORY_DAYS alert, reporting DIO of 238 days, reaches the same conclusion under an alternative calculation: inventory duration is well above the 60-day manufacturing efficiency benchmark. The difference between the two reported DIO measures does not alter the risk assessment; both point to unusually inventory-intensive operations. The LONG_CCC alert of 338 days is also material because it indicates that the cash invested in procurement and production is recovered only after a prolonged operating cycle. A 338-day cash conversion cycle is significantly above the 120-day warning threshold and increases sensitivity to demand interruptions, production planning errors, and stock obsolescence. Receivables declined 7.0% YoY to ¥3.866bn, which is a favorable offset to the inventory build and does not indicate a deterioration in customer collections. Accounts payable declined 14.1% YoY to ¥1.057bn, reducing supplier financing and contributing to the extended operating cash cycle. The combination of higher inventory and lower payables is unfavorable for working-capital cash efficiency even though liquidity remains robust. Reported net income was also supported by a ¥0.758bn gain on sales of investment securities, so operating cash conversion should be evaluated against recurring profit rather than reported net income alone. The balance sheet has sufficient cash and liquid investments to absorb the extended conversion cycle, but future cash generation would benefit materially from inventory normalization.

Dividend Sustainability

The disclosed Q2 dividend was ¥21.00 per share. Based on cumulative Q3 EPS of ¥95.92, the interim dividend represents 21.9% of earnings per share, consistent with the disclosed calculated payout ratio of 22.0%. The full-year forecast calls for DPS of ¥53.00 and EPS of ¥132.28. This implies a forecast dividend-only payout ratio of approximately 40.1%, comfortably below the 60% sustainability benchmark. At 35.79 million issued shares, a ¥53.00 annual dividend implies an aggregate dividend commitment of approximately ¥1.90bn. This compares with forecast net income attributable to owners of ¥4.701bn, providing a reasonable earnings coverage buffer. Retained earnings were ¥25.459bn, materially exceeding the expected annual dividend commitment. The company also holds ¥9.772bn of cash and deposits and ¥8.911bn of investment securities, reinforcing balance-sheet capacity to support distributions. Conservative leverage, with a 0.17x debt-to-equity ratio, further reduces financing constraints on dividends. The main consideration for dividend quality is not solvency but the sustainability of operating profit and inventory-related working-capital demands. Since current net income includes a material gain on sales of investment securities, the recurring earnings base is lower than headline net income suggests. Nevertheless, the indicated 40% forecast payout ratio leaves scope for dividend coverage even after adjusting for a more conservative view of recurring profitability. The dividend outlook appears financially supportable under the stated forecast, with operating-margin recovery and inventory discipline the key factors for maintaining distribution flexibility.

Risk Assessment

Business risks include Inventory and demand risk: inventories rose 24.9% YoY to ¥10.237bn while revenue grew only 0.9%. The reported DIO alerts of 327 days and 238 days indicate elevated exposure to slower sell-through, product obsolescence, discounting, and future inventory valuation losses., Operating-leverage risk: SG&A increased 5.2% YoY while revenue increased 0.9%, driving a 182bp decline in operating margin to 13.1%. If sales momentum does not improve, fixed and discretionary cost growth could continue to pressure operating earnings., Manufacturing execution risk: the 338-day cash conversion cycle indicates a long procurement-to-cash cycle. Production planning, supply-chain management, and finished-goods inventory control are therefore central to earnings and cash-efficiency outcomes., FX risk: reported foreign-exchange gains were ¥0.113bn, equal to 3.0% of operating income. The current reported impact is modest, but foreign-currency translation adjustments of ¥3.648bn within equity indicate that exchange-rate movements can affect the group's financial position., Investment-portfolio risk: investment securities of ¥8.911bn equal 16.7% of total assets. Security valuation movements can affect comprehensive income, and asset sales can introduce volatility into reported earnings..

Financial risks include Working-capital funding risk is elevated operationally despite strong liquidity, because the inventory build and lower trade payables lengthen the cash conversion cycle., Recurring earnings quality risk is present because the ¥0.758bn gain on sales of investment securities represented 22.2% of net income. Repetition cannot be assumed when assessing normalized profitability., Market-value risk exists in the securities portfolio: valuation differences on securities were ¥3.620bn and contributed to accumulated other comprehensive income of ¥8.085bn, making equity partly sensitive to market conditions..

Key concerns include HIGH_INVENTORY_DAYS alert—327 days: root cause is inventory intensity relative to annualized cost of sales; context is far above the 90-day warning level; impact is a heightened risk of stock obsolescence, margin pressure, and cash being tied up in operations., HIGH_INVENTORY_DAYS alert—238 days: root cause is again elevated inventory relative to production and sales throughput; context is far above the 60-day manufacturing benchmark; impact is reduced capital efficiency and increased sensitivity to demand forecasting errors., LONG_CCC alert—338 days: root cause is the combination of high inventory and limited supplier-financing support; context is far above the 120-day warning level; impact is weaker operating cash efficiency and a need to monitor whether inventory converts into Q4 sales., The full-year revenue target requires Q4 revenue of ¥11.762bn, while Q3 cumulative revenue progress of 71.2% is below the standard 75% pace., Operating income fell 11.4% YoY despite stable gross margin, showing that cost absorption below gross profit is the immediate driver of earnings pressure..

Investment Implications

Key takeaways include The company retains a high-quality financial foundation: 85.6% equity ratio, 526.6% current ratio, 340.6% quick ratio, 0.17x debt-to-equity, and 634.33x interest coverage., Core operating profitability remains solid at a 13.1% operating margin and 11.7% net margin, although the operating margin declined 182bp YoY., Reported net income was supported by a ¥0.758bn gain on sales of investment securities, representing 22.2% of net income; recurring earnings momentum was weaker than the headline net-income decline suggests., Inventory management is the dominant operational issue, with inventory up 24.9% YoY and reported DIO measures of 327 days and 238 days., The ¥53.00 full-year DPS forecast implies an approximately 40.1% dividend-only payout ratio, which appears supportable given the capital structure and forecast earnings..

Metrics to watch include Q4 revenue of ¥11.762bn required to meet the ¥40.876bn full-year sales forecast., Q4 operating income of ¥1.430bn required to meet the ¥5.236bn full-year operating-income forecast., SG&A-to-sales ratio after its increase to 46.5% from 44.7% YoY., Inventory balance, inventory days, and the cash conversion cycle following the ¥2.042bn YoY inventory increase., Gross-margin durability around 59.6% and operating-margin recovery from 13.1%., The contribution of investment-security gains and other non-operating items to net income., Market-value movements in ¥8.911bn of investment securities and related valuation differences..

Regarding relative positioning, Shofu is positioned as a financially defensive manufacturer with above-benchmark liquidity, minimal leverage, strong interest coverage, and a good operating-margin profile. Relative to typical manufacturing benchmarks, however, its reported inventory days and cash conversion cycle are materially weak, making working-capital efficiency the most important constraint on capital efficiency and the central determinant of whether operating profitability can translate into durable recurring returns.